ABB to electrify own fleet of 10,00 vehicles by 2030
The Swiss-Swedish group joins three initiatives from The Climate Group
The Swedish-Swiss power and automation technology group ABB has announced that it will completely electrify its fleet of more than 10,000 vehicles by 2030. The company’s climate protection goals also include using only renewable energy, as well as establishing energy efficiency targets and energy management systems
In Sweden, ABB has already begun converting its approximately 700 company cars to all-electric vehicles. In the UK, ABB announced last year that it would convert its 500-plus company cars to a fully electric fleet as early as 2025.
On its way to reaching its ambitious science-based targets, the company commits to electrifying its vehicle fleet by 2030, sourcing 100 percent renewable electricity by 2030 and establishing energy efficiency targets, including the systematic use of energy management systems.
Panorama - ABB strengthens its commitment to renewable energy deployment - Renewable Energy Magazine, at the heart of clean energy journalism renewableenergymagazine.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from renewableenergymagazine.com Daily Mail and Mail on Sunday newspapers.
Miami International Holdings Reports May 2021 Trading Results, MIAX Exchange Group Sets New Market Share Records
USA - English
Share this article
Share this article
PRINCETON, N.J., June 2, 2021 /PRNewswire/ Miami International Holdings, Inc. today reported May 2021 trading results for its U.S. exchange subsidiaries – MIAX
®, MIAX Pearl
® (together, the MIAX Exchange Group™) and the Minneapolis Grain Exchange (MGEX).
The MIAX Exchange Group reported a number of new volume and market share records for multi-list options trading including a 16.56% market share record on May 28, 2021 and a monthly market share record of 14.71% in May 2021. In addition, the MIAX Options Exchange reported a record 1-day total contract volume of 3,094,601 on May 28, 2021 and a record 42,859,476 contracts traded in May 2021.
Share this article
Share this article
SHANGHAI and GAITHERSBURG, Md., June 1, 2021 /PRNewswire/ I-Mab (the Company ) (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that Dr. Ruyi He and Professor Rong Shao have been elected as members of the Company s board of directors. Dr. Ruyi He will serve on the compensation committee and Professor Shao will serve on the corporate governance committee both effective June 1, 2021. We are honored to welcome Dr. He and Professor Shao to our board, and look forward to their wealth of industry experience and breadth of relationships as we transform into a fully integrated global biopharmaceutical company. Both Dr. He and Professor Shao are leading experts in their respective fields, and their appointments will further strengthen I-Mab s next phase of growth, said Dr. Jingwu Zang, Founder, Chairman and Director of I-Mab.